Advertisement

Protracted febrile myalgia as a challenging manifestation of familial Mediterranean fever: case-based review

  • Deniz Gezgin Yıldırım
  • Sevcan A. Bakkaloglu
  • Necla Buyan
Cases with a Message
  • 57 Downloads

Abstract

Protracted febrile myalgia syndrome (PFMS) in familial Mediterranean fever (FMF) patients is a vasculitic condition characterized by severe myalgia, fever, abdominal pain, diarrhea, and arthralgia/arthritis episodes lasting 4–6 weeks. Symptoms typically resolve with corticosteroid treatment. However, in recent years, corticosteroid-resistant PFMS patients have been reported. We herein report five pediatric FMF patients complicated with PFMS. In addition, demographic findings, Mediterranean fever (MEFV) gene analysis, symptoms at disease onset, time interval between the diagnoses of FMF and PFMS, co-existent diseases, and treatment responses were evaluated. Resolution of all PFMS symptoms was accepted as complete response, while decreased symptoms without full recovery as partial response. We searched PubMed using the keywords ‘protracted febrile myalgia’ and ‘anakinra’, and reviewed the literature. There were three male and two female patients. Median age at the diagnosis of FMF was 6 (3–10) years. The time from diagnosis of FMF to the development of PFMS was changed from 0 to 8 (median: 2) years. All of the patients, except one, had homozygous M694V mutation. All patients were treated with corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs) first. Two out of five patients were exhibited partial response, while others exhibited complete response. Patients with partial response to the conventional therapies were treated with anakinra, and achieved a great response after the first dose. Anti-interleukin-1 (IL-1) therapy may be a beneficial and a reasonable treatment option, when there is insufficient response to NSAID and corticosteroid therapies in pediatric PFMS patients.

Keywords

Familial Mediterranean fever Protracted febrile myalgia syndrome Anakinra Corticosteroids 

Notes

Acknowledgements

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest for any pharmaceutical companies.

Informed consent

Written informed consent was obtained from the patients and their parents for publication of this article.

References

  1. 1.
    Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885.  https://doi.org/10.1002/1529-0131(199710)40:10%3C1879::AID-ART23%3E3.0.CO;2-M CrossRefPubMedGoogle Scholar
  2. 2.
    Bernot A, Clepet C, Dasilva C et al (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31.  https://doi.org/10.1038/ng0997-25 CrossRefGoogle Scholar
  3. 3.
    Mattit H, Joma M, Al-Cheikh S, El-Khateeb M, Medlej-Hashim M, Salem N, Delague V, Megarbane A (2006) Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype–genotype correlation. Eur J of Med Genet 49:481–486.  https://doi.org/10.1016/j.ejmg.2006.03.002 CrossRefGoogle Scholar
  4. 4.
    Ben-Chetrit E, Levy M (1998) Colchicine: 1998 update. Semin Arthritis Rheum 28:48–59CrossRefGoogle Scholar
  5. 5.
    van der Hilst JCh, Moutschen M, Messiaen PE, Lauwerys BR, Vanderschueren S (2016) Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature. Biologics 10:75–80.  https://doi.org/10.2147/BTT.S102954 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Langevitz P, Zemer D, Livneh A, Shemer J, Pras M (1994) Protracted myalgia syndrome in patients with familial Mediterranean fever. J Rheumatol 21:1708–1709PubMedGoogle Scholar
  7. 7.
    Fujikawa K, Migita K, Tsukada T, Kawakami T, Eguchi K (2014) Protracted febrile myalgia syndrome in a Japanese patient with fasciitis detected on MRI. Intern Med 53:2817–2819CrossRefGoogle Scholar
  8. 8.
    Soylu A, Kasap B, Türkmen M, Saylam GS, Kavukçu S (2006) Febrile myalgia syndrome in familial Mediterranean fever. J Clin Rheumatol 12:93–96.  https://doi.org/10.1097/01.rhu.0000208635.64537.10 CrossRefPubMedGoogle Scholar
  9. 9.
    Oguz MM, Yazilitas F, Senel S (2016) Protracted myalgia syndrome as the presenting sign of familial mediterranean fever: is group A β-hemolytic streptococcus infection a causative factor? Indian J Pediatr 83:890–891.  https://doi.org/10.1007/s12098-016-2101-7 CrossRefPubMedGoogle Scholar
  10. 10.
    Bircan Z (2010) Steroid-resistant protracted febrile myalgia. Semin Arthritis Rheum 40:1–2.  https://doi.org/10.1016/j.semarthrit.2009.03.004 CrossRefGoogle Scholar
  11. 11.
    Mercan R, Turan A, Bitik B, Tufan A, Haznedaroglu S, Goker B (2016) Rapid resolution of protracted febrile myalgia syndrome with anakinra: report of two cases. Mod Rheumatol 26:458–459.  https://doi.org/10.3109/14397595.2014.882221 CrossRefPubMedGoogle Scholar
  12. 12.
    Kaplan E, Mukamel M, Barash J, Brik R, Padeh S, Berkun Y, Uziel Y, Tauber T, Amir J, Harel L (2007) Protracted febrile myalgia in children and young adults with familial Mediterranean fever: analysis of 15 patients and suggested criteria for working diagnosis. Clin Exp Rheumatol 25:114–117Google Scholar
  13. 13.
    Rom E, Amarilyo G, Levinski Y, Bilavsky E, Goldberg O, Amir J, Harel L (2017) Protracted febrile myalgia syndrome treated with pulse corticosteroids. Semin Arthritis Rheum 47:897–899.  https://doi.org/10.1016/j.semarthrit.2017.10.008 CrossRefPubMedGoogle Scholar
  14. 14.
    Ertekin V, Selimoğlu MA, Alp H, Yilmaz N (2005) Familial Mediterranean fever protracted febrile myalgia in children: report of two cases. Rheumatol Int 25:398–400.  https://doi.org/10.1007/s00296-004-0535-0 CrossRefPubMedGoogle Scholar
  15. 15.
    Bircan Z, Usluer H (2008) Protracted Febrile Myalgia Mimicking Polyarteritis Nodosa. J Clin Rheumatol 14:222–225.  https://doi.org/10.1097/RHU.0b013e318181b46b CrossRefPubMedGoogle Scholar
  16. 16.
    Tufan G, Demir S (2010) Uncommon clinical pattern of FMF: protracted febrile myalgia syndrome. Rheumatol Int 30:1089–1090.  https://doi.org/10.1007/s00296-009-1024-2 CrossRefPubMedGoogle Scholar
  17. 17.
    Duru NS, Civilibal M, Karakoyun M, Payasli M, Elevli M (2010) Protracted febrile myalgia in two children with familial Mediterranean fever. Pediatr Int 52:137–140.  https://doi.org/10.1111/j.1442-200X.2010.03058.x CrossRefGoogle Scholar
  18. 18.
    Senel K, Melikoglu MA, Baykal T, Melikoglu M, Erdal A, Ugur M (2010) Protracted febrile myalgia syndrome in familial Mediterranean fever. Mod Rheumatol 20:410–412.  https://doi.org/10.1007/s10165-010-0288-4 CrossRefPubMedGoogle Scholar
  19. 19.
    Demir K, Carman KB, Kasap B (2012) Concurrent protracted febrile myalgia syndrome in a child with diabetic ketoacidosis. Pediatr Diabetes 13:510–513.  https://doi.org/10.1111/j.1399-5448.2012.00866.x CrossRefPubMedGoogle Scholar
  20. 20.
    Abdel Halim MM, Al-Otaibi T, Donia F, Gheith O, Asif P, Nawas M, Rashad RH, Said T, Nair P, Nampoory N (2015) Protracted febrile myalgia syndrome in a kidney transplant recipient with familial Mediterranean fever. Exp Clin Transpl 13:188–192.  https://doi.org/10.6002/ect.2013.0244 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pediatric Rheumatology, Faculty of MedicineGazi UniversityAnkaraTurkey
  2. 2.Department of Pediatric Rheumatology and Nephrology, Faculty of MedicineGazi UniversityAnkaraTurkey

Personalised recommendations